ArticleClinical and translational medicine2025

Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.

Pui Yeng Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.